本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

再鼎醫藥

25.52
+0.20000.79%
盤後25.550.0300+0.12%19:54 EDT
成交量:119.19萬
成交額:3,072.34萬
市值:28.52億
市盈率:-12.55
高:26.48
開:26.18
低:25.45
收:25.32
52周最高:44.34
52周最低:23.82
股本:1.12億
流通股本:1.10億
量比:1.17
換手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):-2.0329
每股收益(LYR):-2.5984
淨資產收益率:-28.41%
總資產收益率:-14.35%
市淨率:3.60
市盈率(LYR):-9.82

資料載入中...

2025/10/16

重要事件披露

Form 8-K - Current report
2025/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities